| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |